Quarterly report pursuant to Section 13 or 15(d)

Related Party Matters (Details)

v3.22.2.2
Related Party Matters (Details)
3 Months Ended 4 Months Ended 6 Months Ended
May 18, 2022
USD ($)
shares
Mar. 01, 2022
USD ($)
Feb. 28, 2022
USD ($)
Oct. 11, 2021
USD ($)
Dec. 19, 2019
USD ($)
Jun. 30, 2022
USD ($)
shares
Jun. 30, 2021
USD ($)
Apr. 30, 2021
agreement
Jun. 30, 2022
USD ($)
shares
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Related Party Transaction [Line Items]                      
Granted (in shares) | shares                 4,350,000    
Research and development expense           $ 1,427,154 $ 880,672   $ 2,692,807 $ 1,490,328  
Exclusive Sponsored Research Agreement | EHBE                      
Related Party Transaction [Line Items]                      
Initial term of research agreement (in years)       1 year              
Prepaid expenses - related party           50,000     50,000   $ 5,376
Annual retainer amount       $ 200,000              
Research and development expense           50,000     100,000    
Renewal term of research agreement (in years)       1 year              
Notice period for termination (in days)       60 days              
ESRA Agreement, Screening Platform For Anteroposterior Ocular Diseases                      
Related Party Transaction [Line Items]                      
Accounts payable           48,249     48,249    
Research and development expense           103,913     120,000    
Accrued expenses           55,668     55,668    
ESRA Agreement, Screening Platform For Anteroposterior Ocular Diseases | EHBE                      
Related Party Transaction [Line Items]                      
Annual retainer amount   $ 190,500                  
Consulting Agreement                      
Related Party Transaction [Line Items]                      
Accounts payable           2,688     2,688    
Dr. Avtar Dhillon | Independent Contractor Agreement                      
Related Party Transaction [Line Items]                      
Fees incurred under agreement             30,000     60,000  
Accrued expense under agreement           48,908 $ 73,678   87,926 $ 143,278  
Prepaid expenses - related party           $ 0     $ 0   $ 8,056
Jim Heppell                      
Related Party Transaction [Line Items]                      
Granted (in shares) | shares           4,000,000     4,000,000    
Jim Heppell | Emerald Health Sciences                      
Related Party Transaction [Line Items]                      
Ownership (as a percentage)           23.00%     23.00%    
Jim Heppell | Emerald Health Pharmaceuticals, Inc.                      
Related Party Transaction [Line Items]                      
Ownership (as a percentage)           48.00%     48.00%    
Jim Heppell | EHT                      
Related Party Transaction [Line Items]                      
Ownership (as a percentage)           18.00%     18.00%    
Independent Contractor Services Agreement | Dr. Avtar Dhillon                      
Related Party Transaction [Line Items]                      
Monthly fee         $ 10,000            
Related party expenses           $ 0          
Independent Contractor Services Agreement | Jim Heppell                      
Related Party Transaction [Line Items]                      
Monthly fee $ 6,300                    
Initial term of research agreement (in years) 1 year                    
Rights and obligations, renewal term (in year) 1 year                    
Termination terms, period following uncured breach (in days) 60 days                    
Increase In monthly fee $ 16,600                    
Granted (in shares) | shares 4,000,000                    
Severance expense           75,600     $ 75,600    
Accounts payable           6,300     6,300    
Collaborative Research Agreement | Emerald Health Biotechnology Espana, S.L.U.                      
Related Party Transaction [Line Items]                      
Initial term of research agreement (in years)               1 year      
Termination terms, period following uncured breach (in days)               45 days      
Number of collaborative research agreements | agreement               2      
Collaborative Research Agreement | Emerald Health Biotechnology Espana, S.L.U. | Emerald Health Research, Inc                      
Related Party Transaction [Line Items]                      
Subsidiary ownership (as a percent)               100.00%      
Consulting Agreement | Dr. Avtar Dhillon                      
Related Party Transaction [Line Items]                      
Fees incurred under agreement           $ 10,779     $ 19,374    
Consulting Agreement | Immediate Family Member of Management or Principal Owner                      
Related Party Transaction [Line Items]                      
Annual rate per hour     $ 78                
Termination notice period (in days)     15 days